BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24384474)

  • 1. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells.
    Miura S; Hamada S; Masamune A; Satoh K; Shimosegawa T
    Exp Cell Res; 2014 Feb; 321(2):209-18. PubMed ID: 24384474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines.
    Hamada S; Satoh K; Hirota M; Fujibuchi W; Kanno A; Umino J; Ito H; Satoh A; Kikuta K; Kume K; Masamune A; Shimosegawa T
    Cancer Sci; 2009 Jan; 100(1):103-10. PubMed ID: 19018761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
    Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
    Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
    Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
    Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
    Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
    Seidel J; Kunc K; Possinger K; Jehn C; Lüftner D
    Biochem Biophys Res Commun; 2011 Oct; 414(1):226-32. PubMed ID: 21945930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].
    Cheng ZX; Sun B; Wang SJ; Zhou HX; Jia G; Kong R; Wang G; Jiang HC
    Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):446-51. PubMed ID: 22883954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
    Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
    Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
    Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
    Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
    Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
    Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line.
    Hamada S; Satoh K; Hirota M; Kimura K; Kanno A; Masamune A; Shimosegawa T
    J Cell Physiol; 2007 Dec; 213(3):768-74. PubMed ID: 17516553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUB domain containing protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells.
    Orchard-Webb DJ; Lee TC; Cook GP; Blair GE
    BMC Cancer; 2014 Oct; 14():754. PubMed ID: 25301083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of inside-out β1-integrin activation by CDCP1.
    Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
    Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.
    Hiraga R; Kato M; Miyagawa S; Kamata T
    Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.